Evidence map›Paper›PMID 41733325›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Respiratory Syncytial Virus After Chimeric Antigen Receptor T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort.

Maria Isabel Sotelo-Alva, Ofrat Beyar-Katz, Judy Yan, Silvia Escribano-Serrat, Alexander Boardman, Mika Geva, Marina Gomez-Llobell, Jabour Halloun, Hazim Khatib, Malin Hultcrantz and 19 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Maria Isabel Sotelo-AlvaAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Ofrat Beyar-KatzDivision of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Judy YanInfectious Disease Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0009-0005-2174-218X
Silvia Escribano-SerratAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0000-0001-9499-8999
Alexander BoardmanLymphoma Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0000-0001-7169-9275
Mika GevaLymphoma Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Marina Gomez-LlobellAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Jabour HallounDivision of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Hazim KhatibDivision of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Malin HultcrantzMyeloma Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Jennifer LueLymphoma Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Sham MailankodyDepartment of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
Genovefa PapanicolaouInfectious Disease Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Lia PalombaLymphoma Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Jae H ParkDepartment of Medicine, Weill Cornell Medical College, NewYork, New York, USA.
Kai RejeskiAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Jaime SanzAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Michael ScordoAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0000-0002-9484-0240
Susan K SeoInfectious Disease Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Gunjan ShahAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0000-0002-9977-0456
Kayleen ShiDepartment of Medicine III, Hematology/Oncology, LMU University Hospital, Munich, Germany.
Niveen ShibliDivision of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Saad UsmaniDepartment of Medicine, Weill Cornell Medical College, NewYork, New York, USA.
Noriko NishimuraLymphoma Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Zainab ShahidInfectious Disease Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Miguel-Angel PeralesAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Roni ShouvalAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0000-0001-9827-8032
Mini KambojInfectious Disease Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.
Sigrun EinarsdottirAdult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, NewYork, New York, USA.ORCID 0000-0003-4756-6805

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cellsK08CA282987 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Roni Shouval · 2023 to 2026
$1.1M
NCI NIH HHS K08 CA282987NCI NIH HHS P30 CA008748NIH)NIH HHS
6 · The paper itself

Abstract

Among 667 CAR-T recipients, the 2-year cumulative incidence of RSV was 7%, with 29% of diagnosed cases progressing to LRTI. Older age and lymphopenia were associated with severity. Most infections (74%) occurred beyond day +100 (median 8 months). No RSV-attributable deaths occurred. Clinical vigilance is warranted, especially during RSV season.

Indexed as

Immunotherapy, AdoptiveReceptors, Chimeric AntigenRespiratory Syncytial Virus InfectionsAdolescentAdultChildChild, PreschoolFemaleHumansIncidenceInfantLymphopeniaMaleMiddle AgedRetrospective StudiesRisk FactorsReceptors, Chimeric AntigenCAR-T therapyinfection outcomeslymphopeniarespiratory syncytial virus (RSV)

Identifiers

PMID41733325
PMCPMC13131921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.